RxDoctor Payments Data

Landon Humphrey

Family Medicine · Conway, ARNPI 1649447806

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 20.9%.

$4,048in general payments, 2019–2025

Across 78 payments — averaging $51.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$846
  • Angiodynamics, Inc.$760
  • Medtronic$423
  • Stryker$365
  • Endologix LLC$281
  • Paratek Pharmaceuticals, Inc.$207
  • plus $1K from 20 others
$413,166in research payments, 2019–2025

Across 57 payments — averaging $7248.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$323K
  • Novartis$91K

What the payments were for

  • Travel & lodging$98824%
  • Food & beverage$2,30157%
  • Education$76019%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,048 in reported general payments places this provider in the 80th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$72,962
Medicare patients
171
Services billed
1,330

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin16$9,871
EliquisApixaban13$7,382
Celecoxib26$1,333
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$1,255
Atorvastatin Calcium141$929
Albuterol Sulfate HfaAlbuterol Sulfate28$756
Droplet Pen NeedlePen Needle, Diabetic12$619
Amlodipine Besylate113$543
Metoprolol Succinate58$504
Gabapentin34$456
Duloxetine Hcl24$437
Buspirone Hcl24$421
Insulin SyringeSyringe And Needle,insulin,1ml11$401
Oxybutynin Chloride ErOxybutynin Chloride11$370
Trazodone Hcl43$363

Paid to pharmacies, not to this prescriber.

Other family medicine in Conway

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →